p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor
about
Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assemblyDifferential localization of HDAC4 orchestrates muscle differentiationIdentification of Map4k4 as a novel suppressor of skeletal muscle differentiationp38 and extracellular signal-regulated kinases regulate the myogenic program at multiple stepsGATA-dependent recruitment of MEF2 proteins to target promotersSignal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylasesp38 MAPK Signaling in Osteoblast DifferentiationVitamin D signaling in myogenesis: potential for treatment of sarcopeniaTranscriptional regulation of mesoderm genes by MEF2D during early Xenopus developmentRegulation of Muscle Stem Cell Functions: A Focus on the p38 MAPK Signaling PathwayChromatin signaling in muscle stem cells: interpreting the regenerative microenvironmentInduction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cellsGlobal gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomasDeficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cellsEffects of concentric and eccentric contractions on phosphorylation of MAPK(erk1/2) and MAPK(p38) in isolated rat skeletal muscleCyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiationRegulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger proteinInterleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2/STAT3 signalling pathway through cyclin D1 targetingATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cellsAmphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE bindingThe amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivUTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesisComparative expression profiling identifies differential roles for Myogenin and p38α MAPK signaling in myogenesisMulti-tasking role of the mechanosensing protein Ankrd2 in the signaling network of striated muscle.Abl promotes cadherin-dependent adhesion and signaling in myoblasts.Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblastsp38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway.Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.Reconstructing the regulatory kinase pathways of myogenesis from phosphopeptide data.Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities.p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program.Engineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation.Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells.Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways.The role of p38alpha mitogen-activated protein kinase gene in the HELLP syndromeRegulatory interactions between muscle and the immune system during muscle regenerationJAK/STAT signaling and human in vitro myogenesis.
P2860
Q24291439-32BAB20F-45CE-44A3-817A-9D2CEDA9D540Q24291565-B55392AE-94B2-44EF-BC59-54E5CAAA8E5BQ24305188-083C4D80-F5ED-43FA-B6B9-AA11610C1CFBQ24554203-EE60FEF5-F3CA-4463-BBDA-A1DFDE9018A6Q24599616-DE39471C-2E99-4839-AC34-5DB75D907D1BQ24682791-D7C35486-26D5-4CB2-8878-B4D02CB00121Q26747239-64ED3EAC-DFA3-4A62-80B4-4F9C8C3D3C19Q26849642-EA710B56-5D8F-4C11-A7E7-542D5ADBEFE5Q27310774-3B57A3E1-C26B-4143-9892-6F0B77C23AF1Q28078887-7B6A5EC7-6248-4E35-B694-6A4E1AAC4425Q28083474-EB1B6D9B-FC56-49D3-8DA3-C5181508F143Q28217317-5D13B957-1D13-42BB-BD78-B1FEA79ECA23Q28300128-C7DD0DFD-C38D-4C59-A6E1-43A0A0207784Q28343994-3B36D8BE-1A1D-48AD-A6C5-BD7664EE35B4Q28346097-6340E358-A66D-4B2F-AE01-72091A2FCEA7Q28510551-F3E0C9EC-3A83-4993-B6C9-86B9F2865F05Q28513866-7ED2C5D7-BA24-4CA8-B381-AE5AA58AE326Q28566541-DDD3F411-F208-4464-9BFD-A97BE09BC938Q28577947-55829A13-7889-4AD8-8196-64B1548E7B1DQ28579193-06B909B6-B87C-46EB-A684-2425BB8A0DE8Q28582320-E1B49FBF-714D-475E-B62E-24228F1569D9Q28587655-7DC2C5AE-7872-404F-9972-44B485914B36Q29347275-6997A357-9E88-4FCA-BD70-1BD60241BA79Q30010222-257CFA74-137C-491D-B6EE-EB1CCC087FD4Q30156102-CDCC42CB-8CC5-4A4C-83D7-A1FC54496678Q30416251-9AB3798F-FA1B-4C66-A50B-946C66FB7DB0Q30433011-11DA5156-D228-41C0-BFF6-7D2251670424Q30439474-69639233-3958-401E-9D61-2C5119677CDEQ30657563-48E1270B-E045-48A8-92D1-7F8BFCB8EE93Q30666846-2928EC79-FA0B-44E7-96B4-330BF8764279Q31060960-6E32F1EF-CC98-44D2-80EB-29C67FB86C8EQ31810037-8893251C-6549-4427-88A3-AE7D51BC125EQ33589771-68C8AB0D-D6FD-4516-9670-4571CEC0A8CAQ33606453-72DD7F76-5649-40C4-97E9-8ABB408A5E9DQ33673668-4F62AF48-3CFE-4DB5-A9BC-58DC159AA967Q33707676-FEE2E557-6589-4319-9260-678877A8F619Q33778367-8C729B6F-D8C9-4F8C-A9D0-86A95B82B218Q33838890-7411F6B4-7842-4741-AB6C-31457530D0B1Q33841066-44BFEFFC-ADD9-498E-BFF1-70C9683EB94CQ33841492-371291ED-ACF6-4443-B59A-4570B9F72639
P2860
p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor
description
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1999
@ast
im Februar 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/02/19)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/02/19)
@nl
наукова стаття, опублікована в лютому 1999
@uk
name
p38 mitogen-activated protein ...... the Mef2c transcription factor
@ast
p38 mitogen-activated protein ...... the Mef2c transcription factor
@en
p38 mitogen-activated protein ...... the Mef2c transcription factor
@nl
type
label
p38 mitogen-activated protein ...... the Mef2c transcription factor
@ast
p38 mitogen-activated protein ...... the Mef2c transcription factor
@en
p38 mitogen-activated protein ...... the Mef2c transcription factor
@nl
prefLabel
p38 mitogen-activated protein ...... the Mef2c transcription factor
@ast
p38 mitogen-activated protein ...... the Mef2c transcription factor
@en
p38 mitogen-activated protein ...... the Mef2c transcription factor
@nl
P2093
P2860
P3181
P356
P1476
p38 mitogen-activated protein ...... the Mef2c transcription factor
@en
P2093
E. Gredinger
P2860
P304
P3181
P356
10.1074/JBC.274.8.5193
P407
P577
1999-02-19T00:00:00Z